| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 45.6547 | 30 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.843 | 36 |
| GSM780709 | Untreated after 4 days (C3_1) | 39.088 | 4 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.8585 | 31 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.7088 | 31 |
| GSM780721 | Untreated after 4 days (C3_2) | 40.5768 | 8 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 46.8496 | 36 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 43.2258 | 18 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 39.6249 | 5 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 41.2732 | 10 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 42.0538 | 13 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.9532 | 32 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 42.1024 | 14 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 43.721 | 21 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.3048 | 19 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 46.028 | 32 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 46.6036 | 35 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 44.8211 | 26 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.346 | 46 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 41.3574 | 11 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.419 | 34 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.1007 | 37 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 40.705 | 8 |